US 9200090
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted A61KA61K31/715A61K31/732
Quick answer
US patent 9200090 (Galactose-pronged polysaccharides in a formulation for antifibrotic therapies) held by GALECTIN THERAPEUTICS, INC. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALECTIN THERAPEUTICS, INC.
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/715, A61K31/732, A61K39/395, A61K45/06